Abstract
Epilepsy is a common nervous system disease that affects approximately 65 million people worldwide. Because it has diverse clinical manifestations, epilepsy is difficult to diagnose and treat. In contrast to epilepsy, status epilepticus (SE) is not self-terminating. The International League Against Epilepsy (ILAE) classifies SE into two types, SE with prominent motor symptoms and SE without prominent motor symptoms, which primarily include convulsive status epilepticus (CSE) and nonconvulsive status epilepticus (NCSE), respectively. Additionally, complex partial seizures, which are the main presentation in NCSE, have complex clinical manifestations. Refractory status epilepticus (RSE) is resistant to anti-SE drugs and requires special treatment to induce termination. It is currently thought that if the seizure does not terminate or reoccurs after 2–3 types of anti-SE drugs have been administered, it should be classified as RSE. In this chapter, we introduce the definitions, classifications, and clinical features of and evaluations used in epilepsy, SE, and RSE. Moreover, we describe what is currently known regarding epilepsy and SE with a focus on new opinions regarding RSE. Throughout this discussion, we present our own views, and we hope to provide a solid foundation for the studies described in the other chapters presented in this book.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Parra J, Augustijn PB, Geerts Y, van Emde Boas W. Classification of epileptic seizures: a comparison of two systems. Epilepsia. 2001;42:476–82.
Fisher RS, van Emde BW, Blume W, Elger C, Genton P, Lee P, Engel J Jr. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46:470–2.
French JA, Pedley TA. Clinical practice. Initial management of epilepsy. N Engl J Med. 2008;359:166–76.
Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, Engel J Jr, Forsgren L, French JA, Glynn M, Hesdorffer DC, Lee BI, Mathern GW, Moshe SL, Perucca E, Scheffer IE, Tomson T, Watanabe M, Wiebe S. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55:475–82.
Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia. 1981;22:489–501.
Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989;30:389–99.
Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde BW, Engel J, French J, Glauser TA, Mathern GW, Moshe SL, Nordli D, Plouin P, Scheffer IE. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010;51:676–85.
Bwala SA, Gardner-Thorpe C. Intractable epilepsy. Br J Clin Pract. 1990;44:106–10.
Livingston JH. Management of intractable epilepsy. Arch Dis Child. 1991;66:1454–6.
Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshe SL, Perucca E, Wiebe S, French J. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51:1069–77.
World Health Organization. WHO defined daily doses of antiepileptic drugs. 2010. www.WHOCC.no/atc_ddd_index/?code=NO3A0. Accessed 10 Oct 2011.
Morimoto K, Fahnestock M, Racine RJ. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol. 2004;73:1–60.
Guidelines for Epidemiologic Studies on Epilepsy. Commission on Epidemiology and Prognosis, International League against Epilepsy. Epilpsia. 1993;34:592–6.
Lowenstein DH, Bleck T, Macdonald RL. It’s time to revise the definition of status epilepticus. Epilepsia. 1999;40:120–2.
Meierkord H, Boon P, Engelsen B, Gocke K, Shorvon S, Tinuper P, Holtkamp M. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol. 2010;17:348–55.
Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, Laroche SM, Riviello JJ Jr, Shutter L, Sperling MR, Treiman DM, Vespa PM. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17:3–23.
Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, Shorvon S, Lowenstein DH. A definition and classification of status epilepticus—report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56:1515–23.
Engel J Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia. 2001;42:796–803.
Shorvon S. Super-refractory status epilepticus: an approach to therapy in this difficult clinical situation. Epilepsia. 2011;52(Suppl 8):53–6.
Wang X. Diagnosis and treatment of status epilepticus. Beijing: People’s Medical Publishing House; 2010.
Hunter RA. Status epilepticus; history, incidence and problems. Epilepsia. 1959;1:162–88.
Arnautova EN, Nesmeianova TN. A proposed international classifiaction of epileptic seizures. Epilepsia. 1964;5:297–306.
Bleck TP. Convulsive disorders: status epilepticus. Clin Neuropharmacol. 1991;14:191–8.
Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, Handforth A, Faught E, Calabrese VP, Uthman BM, Ramsay RE, Mamdani MB. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339:792–8.
Malek AM, Wilson DA, Martz GU, et al. Mortality following status epilepticus in persons with and without epilepsy. Seizure. 2016;42:7–13.
Rohracher A, Reiter DP, Brigo F, et al. Status epilepticus in the elderly—a retrospective study on 120 patients. Epilepsy Res. 2016;127:317–23.
Mirsattari SM, Gofton TE, Chong DJ. Misdiagnosis of epileptic seizures as manifestations of psychiatric illnesses. Can J Neurol Sci. 2011;38(3):487–93.
Power KN, Gramstad A, Gilhus NE, et al. Prognostic factors of status epilepticus in adults. Epileptic Disord. 2016;18(3):297–304.
Rutka R, Denis A, Vercueil L, Hot P. Psychogenic nonepileptic seizures: current knowledge and contributions of the study of emotions. Sante Ment Que. 2016;41(1):123–39. French.
Wiseman H, Mousa S, Howlett S, et al. A multicenter evaluation of a brief manualized psychoeducation intervention for psychogenic nonepileptic seizures delivered by health professionals with limited experience in psychological treatment. Epilepsy Behav. 2016;63:50–6.
Asadi-Pooya AA, Asadollahi M, Tinker J, et al. Post-epilepsy surgery psychogenic nonepileptic seizures. Epilepsia. 2016;57(10):1691–6.
Russell LA, Abbass AA, Allder SJ, et al. A pilot study of reduction in healthcare costs following the application of intensive short-term dynamic psychotherapy for psychogenic nonepileptic seizures. Epilepsy Behav. 2016;63:17–9.
Rawlings GH, Reuber M. What patients say about living with psychogenic nonepileptic seizures: a systematic synthesis of qualitative studies. Seizure. 2016;41:100–11.
Hayakawa I, Miyama S, Inoue N, et al. Epidemiology of pediatric convulsive status epilepticus with fever in the emergency department: a cohort study of 381 consecutive cases. J Child Neurol. 2016;31(10):1257–64.
Lingappa L, Konanki R, Patel R, et al. Clinical profile and outcome of refractory convulsive status epilepticus in older children from a developing country. Seizure. 2016;36:31–5.
Chentli F, Akkache L, Daffeur K, et al. General seizures revealing macro-adenomas secreting prolactin or prolactin and growth hormone in men. Indian J Endocrinol Metab. 2014;18(3):361–3.
Sorge ST, Hesdorffer DC, Phelan JC, et al. Depression and genetic causal attribution of epilepsy in multiplex epilepsy families. Epilepsia. 2016;57:1643–50.
Camara-Lemarroy CR, Escobedo-Zúñiga N, Ortiz-Zacarias D, et al. Prevalence and impact of irritable bowel syndrome in people with epilepsy. Epilepsy Behav. 2016;63:29–33.
Mameniškienė R, Karmonaitė I, Zagorskis R. The burden of headache in people with epilepsy. Seizure. 2016;41:120–6.
Cooper BB. Alarming syncope, from the admission of air into a vein during an amputation at the shoulder-joint. Med Chir Trans. 1844;27:41–51.
Santy P, Bret J, Marion P. Convulsive and syncopal form of Fallot's tetralogy in a 7-month-old child; Pott’s operation; disappearance of functional symptoms. Lyon Chir. 1950;45(4):456–7.
Gastaut H, Fischer-Williams M. Electro-encephalographic study of syncope; its differentiation from epilepsy. Lancet. 1957;273(7004):1018–25.
Grubb BP, Gerard G, Wolfe DA, et al. Syncope and seizures of psychogenic origin: identification with head-upright tilt table testing. Clin Cardiol. 1992;15(11):839–42.
Bădilă E, Negrea C, Rîpă A, et al. The etiology of syncope in an emergency hospital. Rom J Intern Med. 2016;54(3):173–8.
Sabu J, Regeti K, Mallappallil M, et al. Convulsive syncope induced by ventricular arrhythmia masquerading as epileptic seizures: case report and literature review. J Clin Med Res. 2016;8(8):610–5.
Becker MC, Bass RD, Robbins CM. Pheochromocytoma; a cause of post-partum convulsions. J Med Soc N J. 1949;46(7):339–42.
Leiba A, Bar-Dayan Y, Leker RR, et al. Seizures as a presenting symptom of phaeochromocytoma in a young soldier. J Hum Hypertens. 2003;17(1):73–5.
Anderson NE, Chung K, Willoughby E, et al. Neurological manifestations of phaeochromocytomas and secretory paragangliomas: a reappraisal. J Neurol Neurosurg Psychiatry. 2013;84(4):452–7.
Manger WM. The protean manifestations of pheochromocytoma. Horm Metab Res. 2009;41(9):658–63.
Liu P, Zu X, Liu L. Genetic screening in pheochromocytoma/paraganglioma. Pathol Oncol Res. 2017;23(1):217.
Zou HJ, Li YS, Shan ZY. Genetic analysis and clinical investigation of a pedigree with multiple endocrine neoplasia type 2A: a case report. Oncol Lett. 2016;12(4):2657–9.
Thorling L. Spontanhypoglykämi, insulom. Nord Med. 1948;37(5):217.
Smyth GA, Shields TW, Carroll WW. Functioning insulinoma superimposed on idiopathic epilepsy. Q Bull Northwest Univ Med Sch. 1954;28(2):129–33.
Ding Y, Wang S, Liu J, et al. Neuropsychiatric profiles of patients with insulinomas. Eur Neurol. 2010;63(1):48–51.
Wei J, Liu X, Wu J, et al. Diagnosis and surgical management of insulinomas in 33 consecutive patients at a single institution. Langenbecks Arch Surg. 2016;401(7):1019–25.
Sánchez-Bueno F, Rodríguez González JM, Torres Salmerón G, et al. Prognostic factors in resected pancreatic neuroendocrine tumours: experience in 95 patients. Cir Esp. 2016;94(8):473–80.
Gupta M, Batra A, Hirve M, et al. Paroxysmal dystonic choreoathetosis with symptomatic seizures secondary to hypoglycemia caused by insulinoma. Ann Indian Acad Neurol. 2011;14(4):313–5.
Batouche DD, Kerboua KE, Sadaoui L, et al. Clinical and etiological profile malignant hypertension in children in pediatric intensive care. Ann Cardiol Angeiol. 2016;65(3):165–70.
McEnery PT, Nathan J, Bates SR, et al. Convulsions in children undergoing renal transplantation. J Pediatr. 1989;115(4):532–6.
Wasseff S. Mechanisms of convulsions in eclampsia. Med Hypotheses. 2009;72(1):49–51.
Brown CM, Garovic VD. Drug treatment of hypertension in pregnancy. Drugs. 2014;74(3):283–96.
Moraes KR, Tavares LC, Machado RH, et al. HELLP syndrome: challenges for establishing diagnostic criteria. Pregnancy Hypertens. 2012;2(3):329.
Hingray C, Biberon J, El-Hage W, et al. Psychogenic non-epileptic seizures (PNES). Rev Neurol (Paris). 2016;172(4–5):263–9.
Schachter SC, Brown F, Rowan AJ. Provacative testing for nonepileptic seizures:attitudes and practices in the United States among American Epilepsy Society members. J Epilepsy. 1996;9:249–52.
Sigurdardottir KR, Olafsson E. Incidence of psychogenic seizures in adults: a population-based study in Iceland. Epilepsia. 1998;39(7):749–52.
Szaflarski JP, Ficker DM, Cahill WT, Privitera MD. Four-year incidence of psychogenic nonepileptic seizures in adults in Hamilton County, OH. Neurology. 2000;55(10):1561–3.
Silva W, Giagante B, Saizar R, et al. Clinical features and prognosis of nonepileptic seizures in a developing country. Epilepsia. 2001;42(3):398–401.
Chinta SS, Malhi P, Singhi P, Prabhakar S. Clinical and psychosocial characteristics of children with nonepileptic seizures. Ann Indian Acad Neurol. 2008;11(3):159–63.
Groppel G, Kapitany T, Baumgartner C. Cluster analysis of clinical seizure semiology of psychogenic nonepileptic seizures. Epilepsia. 2000;41(5):610–4.
Elzawahry H, Do CS, Lin K, Benbadis SR. The diagnostic utility of the ictal cry. Epilepsy Behav. 2010;18(3):306–7.
Nikolaev EL, Serli T, Rezvyi G. Psychogenic non-epileptic seizures: issues of comorbidity in the diagnosis and treatment. Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(4):58–61.
Takasaki K, Diaz Stransky A, Miller G. Psychogenic nonepileptic seizures: diagnosis, management, and bioethics. Pediatr Neurol. 2016;62:3–8.
Plioplys S, Doss J, Siddarth P. Risk factors for comorbid psychopathology in youth with psychogenic nonepileptic seizures. Seizure. 2016;38:32–7.
Hupalo M, Smigielski JW, Jaskolski DJ. Optimal time of duration of a long-term video-EEG monitoring in paroxysmal events—a retrospective analysis of 282 sessions in 202 patients. Neurol Neurochir Pol. 2016;50(5):331–5.
Shen W, Bowman ES, Markand ON. Presenting the diagnosis of pseudoseizure. Neurology. 1990;40(5):756–9.
Rathakrishnan R, et al. BOLD signal changes preceding negative responses in EEG-fMRI in patients with focal epilepsy. Epilepsia. 2010;51(9):1837–45.
Thornton R, Moeller F, Levan P, Dubeau F, Gotman J. EEG correlated functional MRI and postoperative outcome in focal epilepsy. J Neurol Neurosurg Psychiatry. 2010;81(8):922–7.
Petramfar P, Yaghoobi E, Nemati R, Asadi-Pooya A. Serum creatine phosphokinase is helpful in distinguishing generalized tonic-clonic seizures from psychogenic nonepileptic seizures and vasovagal syncope. Epilepsy Behav. 2009;15(3):330–2.
Boulding R, Stacey R, Niven R, Fowler SJ. Dysfunctional breathing: a review of the literature and proposal for classification. Eur Respir Rev. 2016;25(141):287–94.
Garssen B, Rijken H. Hyperventilation syndrome. In: Kaptein AA, van der Ploog HM, PJG S, Beunderman R, editors. Behavioural medicine. New York: Wiley; 1990. p. 159–72.
Herman SP, Stickler GB, Lucas AR. Hyperventilation syndrome in children and adolescents: long-term follow up. Pediatrics. 1981;67(2):183–7.
Brashear RE. Hyperventilation syndrome: managing elderly patients. Geriatrics. 1984;39(7):114–5.
Williamson CA, Sheehan KM, Tipirneni R, et al. The association between spontaneous hyperventilation, delayed cerebral ischemia, and poor neurological outcome in patients with subarachnoid hemorrhage. Neurocrit Care. 2015;23(3):330–8.
Perkin GD, Joseph R. Neurological manifestations of the hyperventilation syndrome. J R Soc Med. 1986;79(8):448–50.
Kim CH, Jeong KH, Ahn SH. Vibration- and hyperventilation-induced nystagmus in patients with Ramsay Hunt syndrome with vertigo. Otolaryngol Head Neck Surg. 2015;152(5):912.
Kang BS. A case of hyperventilation syndrome mimicking complex partial seizure: usefulness of EEG monitoring in emergency department. J Epilepsy Res. 2015;5(1):20–2.
Kobayashi M, Kurata S, Sanuki T, Okayasu I, Ayuse T. Management of post-hyperventilation apnea during dental treatment under monitored anesthesia care with propofol. Biopsychosoc Med. 2014;8(1):26.
Zeeman GG, Fleckenstein JL, Twickler DM, Cunningham FG. Cerebral infarction in eclampsia. Am J Obstet Gynecol. 2004;190(3):714–20.
Brewer J, Owens MY, Wallace K, et al. Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia. Am J Obstet Gynecol. 2013;208(6):468.e1–6.
Niedermeyer E, Ribeiro M. Considerations of nonconvulsive status epilepticus. Clin Electroencephalogr. 2000;31:192–5.
Capovilla G, Beccaria F, Beghi E, Minicucci F, Sartori S, Vecchi M. Treatment of convulsive status epilepticus in childhood: recommendations of the Italian League Against Epilepsy. Epilepsia. 2013;54(Suppl 7):23–34.
Bearden S, Eisenschenk S, Uthman B. Diagnosis of nonconvulsive status epilepticus (NCSE) in adults with altered mental status: clinico-electroencephalographic considerations. Am J Electroneurodiagnostic Technol. 2008;48:11–37.
Shorvon S. The definition, classification and frequency of NCSE. Epileptic Disord. 2005;7(13):255–8.
Walker M, Cross H, Smith S, et al. Nonconvulsive status epilepticus: Epilepsy Research Foundation workshop reports. Epileptic Disord. 2005;7:253–96.
Shorvon S, Walker M. Status epilepticus in idiopathic generalized epilepsy. Epilepsia. 2005;46(Suppl 9):73–9.
Towne AR, Waterhouse EJ, Boggs JG, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology. 2000;54:340–5.
Jordan KG. Nonconvulsive status epilepticus in acute brain injury. J Clin Neurophysiol. 1999;16:332–40. discussion 53.
Knake S, Rosenow F, Vescovi M, et al. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia. 2001;42:714–8.
DeLorenzo RJ, Waterhouse EJ, Towne AR, et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia. 1998;39:833–40.
Kennedy JD, Gerard EE. Continuous EEG monitoring in the intensive care unit. Curr Neurol Neurosci Rep. 2012;12:419–28.
Abend NS, Gutierrez-Colina AM, Topjian AA, et al. Nonconvulsive seizures are common in critically ill children. Neurology. 2011;76:1071–7.
Claassen J, Mayer SA, Kowalski RG, Emerson RG, Hirsch LJ. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004;62:1743–8.
Meierkord H, Holtkamp M. Nonconvulsive status epilepticus in adults: clinical forms and treatment. Lancet Neurol. 2007;6:329–39.
Jette N, Claassen J, Emerson RG, Hirsch LJ. Frequency and predictors of nonconvulsive seizures during continuous electroencephalographic monitoring in critically ill children. Arch Neurol. 2006;63:1750–5.
Shorvon S. What is nonconvulsive status epilepticus, and what are its subtypes? Epilepsia. 2007;48(Suppl 8):35–8.
Poothrikovil RP, Gujjar AR, Al-Asmi A, Nandhagopal R, Jacob PC. Predictive value of short-term EEG recording in critically ill adult patients. Neurodiagn J. 2015;55:157–68.
Wusthoff CJ, Dlugos DJ, Gutierrez-Colina A, et al. Electrographic seizures during therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy. J Child Neurol. 2011;26:724–8.
Carrera E, Claassen J, Oddo M, Emerson RG, Mayer SA, Hirsch LJ. Continuous electroencephalographic monitoring in critically ill patients with central nervous system infections. Arch Neurol. 2008;65:1612–8.
Greco F, Cocuzza MD, Smilari P, Sorge G, Pavone L. Nonconvulsive status epilepticus complicating Epstein-Barr virus encephalitis in a child. Case Rep Pediatr. 2014;2014:547396.
Misra UK, Kalita J, Nair PP. Status epilepticus in central nervous system infections: an experience from a developing country. Am J Med. 2008;121:618–23.
Kramer AH, Bleck TP. Neurocritical care of patients with central nervous system infections. Curr Treat Options Neurol. 2008;10:201–11.
Narayanan JT, Murthy JM. Nonconvulsive status epilepticus in a neurological intensive care unit: profile in a developing country. Epilepsia. 2007;48:900–6.
Fernandez-Torre JL, Burgueno P, Ballesteros MA, Hernandez-Hernandez MA, Villagra-Teran N, de Lucas EM. Super-refractory nonconvulsive status epilepticus secondary to fat embolism: a clinical, electrophysiological, and pathological study. Epilepsy Behav. 2015;49:184–8.
Kanazawa Y, Morioka T, Arakawa S, Furuta Y, Nakanishi A, Kitazono T. Nonconvulsive partial status epilepticus mimicking recurrent infarction revealed by diffusion-weighted and arterial spin labeling perfusion magnetic resonance images. J Stroke Cerebrovasc Dis. 2015;24:731–8.
Crepeau AZ, Kerrigan JF, Gerber P, et al. Rhythmical and periodic EEG patterns do not predict short-term outcome in critically ill patients with subarachnoid hemorrhage. J Clin Neurophysiol. 2013;30:247–54.
Fernandez-Torre JL, Hernandez-Hernandez MA. Utility of bilateral Bispectral index (BIS) monitoring in a comatose patient with focal nonconvulsive status epilepticus. Seizure. 2012;21:61–4.
Little AS, Kerrigan JF, McDougall CG, et al. Nonconvulsive status epilepticus in patients suffering spontaneous subarachnoid hemorrhage. J Neurosurg. 2007;106:805–11.
Punia V, Garcia CG, Hantus S. Incidence of recurrent seizures following hospital discharge in patients with LPDs (PLEDs) and nonconvulsive seizures recorded on continuous EEG in the critical care setting. Epilepsy Behav. 2015;49:250–4.
Fujioka H, Urasaki E, Izumihara A, Yamashita K. Nonconvulsive status epilepticus following implantation of subdural grid electrodes in a brain tumor patient. Clin Neurophysiol. 2016;127:975–6.
Vespa PM, Miller C, McArthur D, et al. Nonconvulsive electrographic seizures after traumatic brain injury result in a delayed, prolonged increase in intracranial pressure and metabolic crisis. Crit Care Med. 2007;35:2830–6.
Kadoya M, Onoue H, Kadoya A, Ikewaki K, Kaida K. Refractory status epilepticus caused by anti-NMDA receptor encephalitis that markedly improved following combination therapy with rituximab and cyclophosphamide. Intern Med. 2015;54:209–13.
Alroughani R, Javidan M, Qasem A, Alotaibi N. Nonconvulsive status epilepticus; the rate of occurrence in a general hospital. Seizure. 2009;18:38–42.
Claassen J, Taccone FS, Horn P, Holtkamp M, Stocchetti N, Oddo M. Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM. Intensive Care Med. 2013;39:1337–51.
Greiner MV, Greiner HM, Care MM, Owens D, Shapiro R, Holland K. Adding insult to injury: nonconvulsive seizures in abusive head trauma. J Child Neurol. 2015;30:1778–84.
Azuma H, Akechi T, Furukawa TA. Absence status associated with focal activity and polydipsia-induced hyponatremia. Neuropsychiatr Dis Treat. 2008;4:495–8.
Pro S, Randi F, Pulitano P, Vicenzini E, Mecarelli O. Nonconvulsive status epilepticus characterised exclusively by a language disorder induced by non-ketotic hyperglycaemia. Epileptic Disord. 2011;13:193–6.
Jo YM, Lee SW, Han SY, et al. Nonconvulsive status epilepticus disguising as hepatic encephalopathy. World J Gastroenterol. 2015;21:5105–9.
Jhun P, Kim H. Nonconvulsive status epilepticus in hepatic encephalopathy. West J Emerg Med. 2011;12:372–4.
Bhatt A, Farooq MU, Bhatt S, Majid A, Kassab MY. Periodic lateralized epileptiform discharges: an initial electrographic pattern in reversible posterior leukoencephalopathy syndrome. Neurol Neurochir Pol. 2008;42:55–9.
Cock HR. Drug-induced status epilepticus. Epilepsy Behav. 2015;49:76–82.
Anzellotti F, Ricciardi L, Monaco D, et al. Cefixime-induced nonconvulsive status epilepticus. Neurol Sci. 2012;33:325–9.
Mazzei D, Accardo J, Ferrari A, Primavera A. Levofloxacin neurotoxicity and nonconvulsive status epilepticus (NCSE): a case report. Clin Neurol Neurosurg. 2012;114:1371–3.
Misra UK, Kalita J, Chandra S, Nair PP. Association of antibiotics with status epilepticus. Neurol Sci. 2013;34:327–31.
Anzellotti F, Capasso M, Frazzini V, Onofrj M. Olanzapine-related repetitive focal seizures with lingual dystonia. Epileptic Disord. 2016;18:83–6.
Camacho A, Garcia-Navarro M, Martinez B, Villarejo A, Pomares E. Olanzapine-induced myoclonic status. Clin Neuropharmacol. 2005;28:145–7.
Taniguchi G, Miyajima M, Watanabe M, et al. Nonconvulsive status epilepticus in the elderly associated with newer antidepressants used at therapeutic doses: a report of three cases. Epilepsy Behav Case Rep. 2015;3:8–11.
Schindler BA, Ramchandani D. Partial complex status epilepticus in a lithium-toxic patient. Psychosomatics. 1993;34:521–4.
Maganti R, Gerber P, Drees C, Chung S. Nonconvulsive status epilepticus. Epilepsy Behav. 2008;12:572–86.
Steeghs N, de Jongh FE, Sillevis Smitt PA, van den Bent MJ. Cisplatin-induced encephalopathy and seizures. Anticancer Drugs. 2003;14:443–6.
Patterson DM, Aries J, Hyare H, Holder D, Rees J, Lee SM. Nonconvulsive status epilepticus and leucoencephalopathy after high-dose methotrexate. J Clin Oncol. 2011;29:e459–61.
Bhatt A, Farooq MU, Majid A, Kassab M. Chemotherapy-related posterior reversible leukoencephalopathy syndrome. Nat Clin Pract Neurol. 2009;5:163–9.
Kim TK, Jung ES, Park JM, Kang K, Lee WW, Lee JJ. An atypical presentation of subacute encephalopathy with seizures in chronic alcoholism syndrome. J Epilepsy Res. 2016;6:28–30.
Fernandez-Torre JL, Kaplan PW. Subacute encephalopathy with seizures in alcoholics (SESA syndrome) revisited. Seizure. 2014;23:393–6.
Jirsch J, Hirsch LJ. Nonconvulsive seizures: developing a rational approach to the diagnosis and management in the critically ill population. Clin Neurophysiol. 2007;118:1660–70.
Bender MB. Diagnostic aids in the mental and aphasic status. J Mt Sinai Hosp N Y. 1966;33:208–12.
Ericson EJ, Gerard EE, Macken MP, Schuele SU. Aphasic status epilepticus: electroclinical correlation. Epilepsia. 2011;52:1452–8.
Toledo M, Munuera J, Sueiras M, Rovira R, Alvarez-Sabin J, Rovira A. MRI findings in aphasic status epilepticus. Epilepsia. 2008;49:1465–9.
Michael M, Tsatsou K, Ferrie CD. Panayiotopoulos syndrome: an important childhood autonomic epilepsy to be differentiated from occipital epilepsy and acute non-epileptic disorders. Brain Dev. 2010;32:4–9.
Ferrie CD, Caraballo R, Covanis A, et al. Autonomic status epilepticus in Panayiotopoulos syndrome and other childhood and adult epilepsies: a consensus view. Epilepsia. 2007;48:1165–72.
Mizobuchi M. Nonconvulsive status epilepticus. Brain Nerve. 2016;68:451–62.
Marchi NA, Novy J, Faouzi M, Stahli C, Burnand B, Rossetti AO. Status epilepticus: impact of therapeutic coma on outcome. Crit Care Med. 2015;43:1003–9.
Rossetti AO, Trinka E, Stahli C, Novy J. New ILAE versus previous clinical status epilepticus semiologic classification: analysis of a hospital-based cohort. Epilepsia. 2016;57:1036–41.
Sutter R, Kaplan PW. Electroencephalographic criteria for nonconvulsive status epilepticus: synopsis and comprehensive survey. Epilepsia. 2012;53(Suppl 3):1–51.
Shafi MM, Westover MB, Cole AJ, Kilbride RD, Hoch DB, Cash SS. Absence of early epileptiform abnormalities predicts lack of seizures on continuous EEG. Neurology. 2012;79:1796–801.
Yazdi JS, Schumaker JA. Treatment of refractory status epilepticus with vagus nerve stimulator in an elderly patient. World Neurosurg. 2016;5:620.e1–7.
Vyas DD, Dash GK. Supra-recommendation treatment of super-refractory status epilepticus. J Epilepsy Res. 2016;6(1):39–41.
Sheikh Z, Wang W, Hillen M. A young man with recurrent coma and refractory status epilepticus. JAMA Neurol. 2016;73(10):1243–4.
Prasanth S, et al. Refractory status epilepticus due to pneumococcal meningitis in an infant with congenital immunodeficiency. J Pediatr Neurosci. 2016;11(2):125–7.
Niquet J, et al. Benzodiazepine-refractory status epilepticus: pathophysiology and principles of treatment. Ann N Y Acad Sci. 2016;1378(1):166–73.
Newey CR, et al. Observed medical and surgical complications of prolonged barbiturate coma for refractory status epilepticus. Ther Adv Drug Saf. 2016;7(5):195–203.
Legriel S, Oddo M, Brophy GM. What’s new in refractory status epilepticus? Intensive Care Med. 2017;43(4):543–6.
KK K. Super refractory status epilepticus. J Assoc Physicians India. 2016;64(1):131.
Johnson EL, Martinez NC, Ritzl EK. EEG characteristics of successful burst suppression for refractory status epilepticus. Neurocrit Care. 2016;25(3):407–14.
Hofler J, et al. (S)-Ketamine in refractory and super-refractory status epilepticus: a retrospective study. CNS Drugs. 2016;30(9):869–76.
Hocker S, et al. Progressive brain atrophy in super-refractory status epilepticus. JAMA Neurol. 2016;73(10):1201–7.
Farias-Moeller R, et al. A practical approach to ketogenic diet in the pediatric intensive care unit for super-refractory status epilepticus. Neurocrit Care. 2017;26(2):267–72.
Dillien P, et al. New-onset refractory status epilepticus: more investigations, more questions. Case Rep Neurol. 2016;8(2):127–33.
Chiusolo F, et al. From intravenous to enteral ketogenic diet in PICU: a potential treatment strategy for refractory status epilepticus. Eur J Paediatr Neurol. 2016;20(6):843–7.
Bick SK, et al. Anterior temporal lobectomy for refractory status epilepticus in herpes simplex encephalitis. Neurocrit Care. 2016;25(3):458–63.
Bennett KS. Treatment of refractory status epilepticus in children: current practice and opportunities to improve care. Pediatr Crit Care Med. 2016;17(10):1006–7.
Beg JM, et al. Burden of illness for super-refractory status epilepticus patients. J Med Econ. 2017;20(1):45–53.
Appavu B, et al. Ketogenic diet treatment for pediatric super-refractory status epilepticus. Seizure. 2016;41:62–5.
Kramer U, et al. Severe refractory status epilepticus owing to presumed encephalitis. J Child Neurol. 2005;20(3):184–7.
Madzar D, et al. Effects of clobazam for treatment of refractory status epilepticus. BMC Neurol. 2016;16(1):202.
Lebedev VV, Ioffe IuS. Cooling of the brain in refractory status epilepticus. Vopr Neirokhir. 1972;36(2):32–6.
Vajda FJ, et al. Rectal administration of sodium valproate in status epilepticus. Neurology. 1978;28(9 Pt 1):897–9.
Young GB, et al. Anesthetic barbiturates in refractory status epilepticus. Can J Neurol Sci. 1980;7(4):291–2.
Orlowski JP, et al. Hypothermia and barbiturate coma for refractory status epilepticus. Crit Care Med. 1984;12(4):367–72.
Rosati A, et al. Efficacy of ketamine in refractory convulsive status epilepticus in children: a protocol for a sequential design, multicentre, randomised, controlled, open-label, non-profit trial (KETASER01). BMJ Open. 2016;6(6):e011565.
Miras VA, et al. Effectiveness of electroconvulsive therapy for refractory status epilepticus in febrile infection-related epilepsy syndrome. Neuropediatrics. 2017;48(1):45–8.
Delaj L, et al. Refractory and super-refractory status epilepticus in adults: a 9-year cohort study. Acta Neurol Scand. 2017;135(1):92–9.
Sahin M, et al. Outcome of severe refractory status epilepticus in children. Epilepsia. 2001;42(11):1461–7.
Mayer SA, et al. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002;59(2):205–10.
Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol. 2005;62(11):1698–702.
Barzegar M, et al. Refractory convulsive status epilepticus in children: etiology, associated risk factors and outcome. Iran J Child Neurol. 2015;9(4):24–31.
Rohracher A, et al. Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit. Epilepsy Behav. 2015;49:354–8.
Sinha S, et al. Refractory status epilepticus: a developing country perspective. J Neurol Sci. 2010;290(1–2):60–5.
Juhasz C, et al. Successful surgical treatment of an inflammatory lesion associated with new-onset refractory status epilepticus. Neurosurg Focus. 2013;34(6):E5.
Lai A, et al. Functional outcome of prolonged refractory status epilepticus. Crit Care. 2015;19:199.
Liberalesso PB, et al. Higher mortality rate is associated with advanced age and periodic lateralized epileptiform discharges in patients with refractory status epilepticus. Arq Neuropsiquiatr. 2013;71(3):153–8.
Ong CT, et al. Age-dependent sex difference of the incidence and mortality of status epilepticus: a twelve year nationwide population-based cohort study in Taiwan. PLoS One. 2015;10(3):e0122350.
Cardoso I, et al. Refractory status epilepticus in children: characterisation of epilepsies, continuous electroencephalographic monitoring and response to treatment. Rev Neurol. 2013;56(8):401–8.
Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology. 1993;43(3 Pt 1):483–8.
Lowenstein DH. The management of refractory status epilepticus: an update. Epilepsia. 2006;47(Suppl 1):35–40.
Scholtes FB, Renier WO, Meinardi H. Generalized convulsive status epilepticus: causes, therapy, and outcome in 346 patients. Epilepsia. 1994;35(5):1104–12.
Glaser CA, et al. Refractory status epilepticus in suspect encephalitis. Neurocrit Care. 2008;9(1):74–82.
Sutter R, et al. Mortality and recovery from refractory status epilepticus in the intensive care unit: a 7-year observational study. Epilepsia. 2013;54(3):502–11.
Murthy JM. Refractory status epilepticus. Neurol India. 2006;54(4):354–8.
Giovannini G, et al. A one-year prospective study of refractory status epilepticus in Modena, Italy. Epilepsy Behav. 2015;49:141–5.
Sivakumar S, et al. Clobazam: an effective add-on therapy in refractory status epilepticus. Epilepsia. 2015;56(6):e83–9.
Webster DL, et al. Status epilepticus: a possible association with human metapneumovirus infection. Pediatrics. 2014;133(3):e747–50.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Chen, Y., Li, S. (2017). Epilepsy, Status Epilepticus, and Refractory Status Epilepticus. In: Wang, X., Li, S. (eds) Refractory Status Epilepticus. Springer, Singapore. https://doi.org/10.1007/978-981-10-5125-8_1
Download citation
DOI: https://doi.org/10.1007/978-981-10-5125-8_1
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-5124-1
Online ISBN: 978-981-10-5125-8
eBook Packages: MedicineMedicine (R0)